← All trials
NCT06872151
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 4, 2025
- Primary completion
- Mar 4, 2025
- Completion date
- May 30, 2025
- First posted
- Mar 12, 2025
- Last posted
- Jul 2, 2025
- Enrollment
- 114
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CagliariLead sponsor
- University of CagliariSponsor investigator
- University of CagliariOfficial
- University of Roma La SapienzaCollaborator
- University of FerraraCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.